Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 14:13:1094346.
doi: 10.3389/fimmu.2022.1094346. eCollection 2022.

COVID-19 and monkeypox co-infection: A rapid systematic review

Affiliations

COVID-19 and monkeypox co-infection: A rapid systematic review

Amr Ehab El-Qushayri et al. Front Immunol. .

Abstract

In this paper we aimed to study the characteristics, laboratory data and outcomes of monkeypox virus (MPV) and COVID-19 co-infection. On 2nd October 2022, we used the search term "("monkeypox virus" OR "MPV" OR "monkey pox" OR "monkeypox") AND ("COVID-19" OR "COVID 19" OR "novel coronavirus" OR "SARS-CoV-2")" in five databases to collect the relevant articles. We found three male patients, who had sex with men prior to the infection, had multiple comorbid conditions, were diagnosed with PCR, and were admitted to the hospital. The length of hospital stay was 4, 6, and 9 days. On admission, two cases had multiple vesicular lesions on various sites of the body associated with tonsillar inflammation, while the third case had genital ulcers and inguinal lymph node enlargement. All cases were managed in the hospital and recovered well. It might still be too early to establish solid evidence about the exact cause-effect association between SARS-CoV-2 and MPV co-infection and patient's outcomes because of the current low sample size. Accordingly, future relevant investigations, estimating the risk ratio of this association are needed to formulate definite evidence.

Keywords: COVID19; SARS- CoV2; coinfection - disease; infection; monkeypox.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. El-Qushayri AE, Kamel AMA, Reda A, Ghozy S. Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence. Rev Med Virol (2022) 32(5):e2339. - PMC - PubMed
    1. Størdal K, Ruiz PL, Greve-Isdahl M, Surén P, Knudsen PK, Gulseth HL, et al. Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: A nationwide population-based study. BMJ Open (2022) 12(3):e056549. - PMC - PubMed
    1. Mertoglu C, Huyut MT, Arslan Y, Ceylan Y, Coban TA. How do routine laboratory tests change in coronavirus disease 2019? Scand J Clin Lab Invest (2021) 81(1):24–33. - PubMed
    1. Sah R, Mohanty A, Abdelaal A, Reda A, Rodriguez-Morales AJ, Henao-Martinez AF. First monkeypox deaths outside Africa: no room for complacency. Ther Adv Infect Disease (2022) 9:20499361221124027. - PMC - PubMed
    1. Ali MR, Hasan MA, Rahman MS, Billah M, Karmakar S, Shimu AS, et al. Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience. J infect Public Health (2021) 14(10):1367–74. - PMC - PubMed

Publication types